1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
2. Howlader N, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA. SEER Cancer Statistics Review 1975–2009 (Vintage 2009 Populations). Bethesda, MD: National Cancer Institute; 2012. based on November 2011 SEER data submission, posted to the SEER web site
3. Reed AB, Parekh DJ. The utility of 5-alpha reductase inhibitors in the prevention and diagnosis of prostate cancer. Curr Opin Urol. 2009;19(3):238–42.
4. Stewart BW, Wild CP, World Health Organization. World Cancer Report 2014. Chapter 1. Lyon: IARC Publications; 2014.
5. Nomera A, Kolonel L. Prostate cancer: a current prospective. Am J Epidemiol. 1991;13(1):200–27.